• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估第二原发性癌症发病率的方法及其在监测、流行病学和最终结果(SEER)计划中与吸烟相关癌症的应用

Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.

作者信息

Begg C B, Zhang Z F, Sun M, Herr H W, Schantz S P

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Am J Epidemiol. 1995 Sep 15;142(6):653-65. doi: 10.1093/oxfordjournals.aje.a117689.

DOI:10.1093/oxfordjournals.aje.a117689
PMID:7653476
Abstract

The Surveillance, Epidemiology, and End Results (SEER) database is used to estimate the standardized incidence ratios (SIRs) of second primaries for all pairs of smoking-related cancers and to interpret the results in the context of our knowledge of the known effects of smoking on the incidence of each of the individual cancers. In evaluating the simultaneous incidence of two cancers, one must recognize the inherent duality of the two relevant SIRs linking the two cancers (e.g., A and B), namely, the SIRs of A following B and B following A. Under fairly general assumptions, the two SIRs are seen to be equal, and departures from equality suggest changes in risk status or the introduction of new risk factors after the incidence of the first primary. Based on these observations, a methodological strategy is developed. The data reveal several clear patterns. First, short-term incidence is uniformly much greater than long-term incidence. Second, the SIRs are consistently much higher for women than for men, for every pair of cancers studied. Third, the magnitudes of the SIRs are generally high and often substantially higher than would be expected on the basis of the known risks of smoking. Exceptionally high SIRs are observed between kidney and bladder cancer and between head and neck and esophageal cancer. Various influences may affect these high observed SIRs, including artifactual influences such as diagnostic, surveillance, and misclassification biases, and the effect of different exposure prevalences on subsequent SIRs, which may to some extent explain the strong sex differences. However, these artifacts do not appear to explain the magnitude of the observed SIRs, especially the very strong associations between kidney and bladder cancer and between head and neck and esophageal cancer. It seems likely that other factors play a role, including, possibly, host susceptibility factors or additional common risk factors other than smoking. Although multiple primary cancers are rare, they represent an especially fruitful population for detailed epidemiologic study.

摘要

监测、流行病学和最终结果(SEER)数据库用于估计所有与吸烟相关癌症对的第二原发癌的标准化发病比(SIR),并根据我们对吸烟对每种个体癌症发病率已知影响的了解来解释结果。在评估两种癌症的同时发病率时,必须认识到连接这两种癌症(例如A和B)的两个相关SIR的内在双重性,即B发生后A的SIR和A发生后B的SIR。在相当一般的假设下,这两个SIR被认为是相等的,而偏离相等则表明在第一个原发癌发病后风险状态发生了变化或引入了新的风险因素。基于这些观察结果,制定了一种方法策略。数据揭示了几个明显的模式。首先,短期发病率始终远高于长期发病率。其次,在所研究的每对癌症中,女性的SIR始终远高于男性。第三,SIR的幅度通常很高,而且往往大大高于基于已知吸烟风险所预期的水平。在肾癌和膀胱癌之间以及头颈癌和食管癌之间观察到异常高的SIR。各种影响可能会影响这些观察到的高SIR,包括诊断、监测和错误分类偏差等人为影响,以及不同暴露患病率对后续SIR的影响,这在一定程度上可能解释了强烈的性别差异。然而,这些人为因素似乎并不能解释观察到的SIR的幅度,特别是肾癌和膀胱癌之间以及头颈癌和食管癌之间非常强的关联。似乎其他因素也起了作用,包括可能的宿主易感性因素或除吸烟外的其他共同风险因素。虽然多重原发性癌症很少见,但它们是详细流行病学研究的一个特别有成果的人群。

相似文献

1
Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.评估第二原发性癌症发病率的方法及其在监测、流行病学和最终结果(SEER)计划中与吸烟相关癌症的应用
Am J Epidemiol. 1995 Sep 15;142(6):653-65. doi: 10.1093/oxfordjournals.aje.a117689.
2
Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.继发原发性肾癌风险:一项基于人群的研究。
Clin Genitourin Cancer. 2017 Oct;15(5):e747-e754. doi: 10.1016/j.clgc.2017.02.004. Epub 2017 Feb 27.
3
Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.吸烟相关及非吸烟相关癌症患者发生第二原发癌的风险。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1765-1779. doi: 10.1007/s00432-020-03232-8. Epub 2020 Apr 30.
4
Italian cancer figures, report 2013: Multiple tumours.《2013年意大利癌症数据报告:多发性肿瘤》
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.
5
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.104760例宫颈癌幸存者中的二次癌症:长期风险评估
J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. doi: 10.1093/jnci/djm201. Epub 2007 Oct 30.
6
Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.美国与吸烟相关癌症幸存者的第二原发恶性肿瘤风险和负担的变化趋势。
Int J Cancer. 2019 Jul 1;145(1):143-153. doi: 10.1002/ijc.32101. Epub 2019 Jan 24.
7
Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.原位和侵袭性皮肤黑色素瘤患者的继发原发性癌症。
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S69-77. doi: 10.1016/j.jaad.2011.04.033.
8
Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.肛门癌幸存者中与人类乳头瘤病毒相关的第二癌症风险增加。
Cancer. 2017 Oct 15;123(20):4013-4021. doi: 10.1002/cncr.30828. Epub 2017 Jun 13.
9
Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?非小细胞肺癌作为既往有恶性肿瘤患者的第二原发性肿瘤:哪些人有风险?
Clin Lung Cancer. 2017 Sep;18(5):543-550.e3. doi: 10.1016/j.cllc.2017.02.007. Epub 2017 Mar 2.
10
Association of esophageal adenocarcinoma with other subsequent primary cancers.食管腺癌与其他后续原发性癌症的关联。
J Clin Gastroenterol. 2006 May-Jun;40(5):405-11. doi: 10.1097/00004836-200605000-00008.

引用本文的文献

1
Risk of developing a second primary cancer following a renal cell carcinoma: a systematic review and meta-analysis.肾细胞癌后发生第二原发性癌症的风险:一项系统评价和荟萃分析。
Int Urol Nephrol. 2025 Sep 18. doi: 10.1007/s11255-025-04794-7.
2
A New Strategy for Evaluating the Impact of Epidemiologic Risk Factors for Cancer With Application to Melanoma.一种评估癌症流行病学危险因素影响的新策略及其在黑色素瘤中的应用
J Am Stat Assoc. 1998;93(442):415-426. doi: 10.1080/01621459.1998.10473691.
3
Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study.
异时性双原发性癌症乳腺癌幸存者的特征及生存分析:一项回顾性队列研究
Transl Cancer Res. 2023 Apr 28;12(4):939-948. doi: 10.21037/tcr-23-301. Epub 2023 Apr 24.
4
Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.吸烟相关及非吸烟相关癌症患者发生第二原发癌的风险。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1765-1779. doi: 10.1007/s00432-020-03232-8. Epub 2020 Apr 30.
5
Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers.索引潜在人乳头瘤病毒(HPV)相关癌症后后续恶性肿瘤的风险。
Cancer Epidemiol. 2020 Feb;64:101649. doi: 10.1016/j.canep.2019.101649. Epub 2019 Dec 6.
6
Multiple primary malignancies of six organs in a Japanese male patient: A case report.一名日本男性患者出现六个器官的多原发性恶性肿瘤:病例报告。
Mol Clin Oncol. 2019 May;10(5):511-515. doi: 10.3892/mco.2019.1819. Epub 2019 Mar 4.
7
Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.与索引型人乳头瘤病毒相关癌症相关的第二原发性癌症风险的趋势。
JAMA Netw Open. 2018 Sep 7;1(5):e181999. doi: 10.1001/jamanetworkopen.2018.1999.
8
Incidence of Second Malignancy in Patients with Papillary Thyroid Cancer from Surveillance, Epidemiology, and End Results 13 Dataset.来自监测、流行病学和最终结果13数据集的甲状腺乳头状癌患者的第二原发性恶性肿瘤发病率。
J Thyroid Res. 2018 Jun 26;2018:8765369. doi: 10.1155/2018/8765369. eCollection 2018.
9
Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌首次治疗后第二原发性恶性肿瘤的发生率和风险。
JAMA Otolaryngol Head Neck Surg. 2018 Aug 1;144(8):727-737. doi: 10.1001/jamaoto.2018.0993.
10
Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.肾皮质肿瘤中的第二原发性恶性肿瘤:来自单一机构的最新评估
World J Urol. 2016 Dec;34(12):1667-1672. doi: 10.1007/s00345-016-1832-4. Epub 2016 Apr 22.